CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Allergan Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERFeb 11, 2018

Explore Allergan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 19, 2023Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing Thereof1
Feb 8, 2023High Potency Pancreatin Pharmaceutical Compositions1
Oct 7, 2020High Potency Pancreatin Pharmaceutical Compositions1
Mar 6, 20195-Aminosalicylic Acid Capsule Formulation1
Nov 8, 2017Enteric Coated, Low-Strength Pancrelipase Formulations1

Top competitors of Allergan Pharmaceuticals

List of top competitors of Allergan Pharmaceuticals based on patent oppositions.